Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, Engh AM.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):367-402. doi: 10.6004/jnccn.2019.0018.

PMID:
30959471
2.

Comparison of keystone flaps and skin grafts for oncologic reconstruction: A retrospective review.

Darrach H, Kokosis G, Bridgham K, Stone JP, Lange JR, Sacks JM.

J Surg Oncol. 2019 Jun;119(7):843-849. doi: 10.1002/jso.25394. Epub 2019 Feb 6.

PMID:
30729527
3.

Unbiased High-Precision Cell Mechanical Measurements with Microconstrictions.

Lange JR, Metzner C, Richter S, Schneider W, Spermann M, Kolb T, Whyte G, Fabry B.

Biophys J. 2017 Apr 11;112(7):1472-1480. doi: 10.1016/j.bpj.2017.02.018.

4.

Nanoscopic imaging of thick heterogeneous soft-matter structures in aqueous solution.

Bartsch TF, Kochanczyk MD, Lissek EN, Lange JR, Florin EL.

Nat Commun. 2016 Sep 6;7:12729. doi: 10.1038/ncomms12729.

5.

Influence of αvβ3 integrin on the mechanical properties and the morphology of M21 and K562 cells.

Lange JR, Goldmann WH, Alonso JL.

Biochem Biophys Res Commun. 2016 Sep 23;478(3):1280-5. doi: 10.1016/j.bbrc.2016.08.111. Epub 2016 Aug 20.

PMID:
27553273
6.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.

PMID:
27496110
7.

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Apr;14(4):450-73.

PMID:
27059193
8.

Ischemic Optic Neuropathies.

McKeever RG, Greenberg MI, Lange JR.

N Engl J Med. 2015 Oct 22;373(17):1676-7. doi: 10.1056/NEJMc1509058. No abstract available.

PMID:
26488709
9.

Migration in Confined 3D Environments Is Determined by a Combination of Adhesiveness, Nuclear Volume, Contractility, and Cell Stiffness.

Lautscham LA, Kämmerer C, Lange JR, Kolb T, Mark C, Schilling A, Strissel PL, Strick R, Gluth C, Rowat AC, Metzner C, Fabry B.

Biophys J. 2015 Sep 1;109(5):900-13. doi: 10.1016/j.bpj.2015.07.025.

10.

Microconstriction arrays for high-throughput quantitative measurements of cell mechanical properties.

Lange JR, Steinwachs J, Kolb T, Lautscham LA, Harder I, Whyte G, Fabry B.

Biophys J. 2015 Jul 7;109(1):26-34. doi: 10.1016/j.bpj.2015.05.029.

11.

Epidemiology, risk factors, prevention, and early detection of melanoma.

Azoury SC, Lange JR.

Surg Clin North Am. 2014 Oct;94(5):945-62, vii. doi: 10.1016/j.suc.2014.07.013. Epub 2014 Aug 6. Review.

PMID:
25245960
12.

Lithium-induced transient euthyroid hyperthyroxinemia: a case report.

Chekuri L, Lange JR, Thapa PB.

Prim Care Companion CNS Disord. 2014;16(2). pii: PCC.13l01604. doi: 10.4088/PCC.13l01604. No abstract available.

13.

Melanoma, version 4.2014.

Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daniels GA, Daud A, Dimaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 May;12(5):621-9.

PMID:
24812131
14.

Cell and tissue mechanics in cell migration.

Lange JR, Fabry B.

Exp Cell Res. 2013 Oct 1;319(16):2418-23. doi: 10.1016/j.yexcr.2013.04.023. Epub 2013 May 9. Review.

15.

Melanoma, version 2.2013: featured updates to the NCCN guidelines.

Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daud A, Dimaio D, Fleming MD, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, McMillian N, Ho M; National Comprehensive Cancer Network (NCCN).

J Natl Compr Canc Netw. 2013 Apr 1;11(4):395-407.

PMID:
23584343
16.

Surgical treatment of melanoma patients with early sentinel node involvement.

Hardin RE, Lange JR.

Curr Treat Options Oncol. 2012 Sep;13(3):318-26. doi: 10.1007/s11864-012-0202-8. Review.

PMID:
22810837
17.

Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.

Aubert Y, Bohl MA, Lange JR, Diol NR, Allers KA, Sommer B, Datson NA, Abbott DH.

Psychoneuroendocrinology. 2013 Jan;38(1):145-54. doi: 10.1016/j.psyneuen.2012.05.011. Epub 2012 Jun 21.

PMID:
22727480
18.

Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma.

Mu E, Lange JR, Strouse JJ.

Cancer. 2012 May 15;118(10):2700-7. doi: 10.1002/cncr.26578. Epub 2011 Oct 5.

19.

Melanoma.

Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daud A, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Mar;10(3):366-400. No abstract available.

PMID:
22393197
20.

Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.

Aubert Y, Gustison ML, Gardner LA, Bohl MA, Lange JR, Allers KA, Sommer B, Datson NA, Abbott DH.

J Sex Med. 2012 Mar;9(3):694-707. doi: 10.1111/j.1743-6109.2011.02616.x. Epub 2012 Feb 3.

21.

Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.

Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, Tsangaris TN, Sukumar S.

Sci Transl Med. 2011 Oct 26;3(106):106ra108. doi: 10.1126/scitranslmed.3002368.

22.

Melanoma in the older patient: measuring frailty as an index of survival.

Lange JR, Kang S, Balch CM.

Ann Surg Oncol. 2011 Dec;18(13):3531-2. doi: 10.1245/s10434-011-2015-6. No abstract available.

PMID:
21879274
23.

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.

Chumsri S, Jeter S, Jacobs LK, Nassar H, Armstrong DK, Emens LA, Fetting JH, Lange JR, Riley C, Tsangaris TN, Wolff AC, Zellars R, Zhang Z, Stearns V.

Clin Breast Cancer. 2010 Feb;10(1):40-5. doi: 10.3816/CBC.2010.n.005.

PMID:
20133257
24.

Melanoma.

Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK; NCCN Melanoma Panel.

J Natl Compr Canc Netw. 2009 Mar;7(3):250-75. No abstract available.

PMID:
19401060
25.

Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.

Zellars RC, Stearns V, Frassica D, Asrari F, Tsangaris T, Myers L, DiPasquale S, Lange JR, Jacobs LK, Emens LA, Armstrong DK, Fetting JH, Garrett-Mayer E, Davidson NE, Wolff AC.

J Clin Oncol. 2009 Jun 10;27(17):2816-22. doi: 10.1200/JCO.2008.20.0139. Epub 2009 Mar 30.

26.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

PMID:
19273706
27.

Sentinel lymph node biopsy in melanoma.

Hueman MT, Lange JR.

Curr Treat Options Oncol. 2008 Dec;9(4-6):243-50. doi: 10.1007/s11864-008-0074-0. Epub 2008 Nov 8.

PMID:
18998214
28.

Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.

Bilimoria KY, Balch CM, Bentrem DJ, Talamonti MS, Ko CY, Lange JR, Winchester DP, Wayne JD.

Ann Surg Oncol. 2008 Jun;15(6):1566-76. doi: 10.1245/s10434-008-9885-2. Epub 2008 Apr 15.

PMID:
18414952
29.

Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.

Carraway HE, Wang S, Blackford A, Guo M, Powers P, Jeter S, Davidson NE, Argani P, Terrell K, Herman JG, Lange JR.

Breast Cancer Res Treat. 2009 Mar;114(2):315-25. doi: 10.1007/s10549-008-0004-7. Epub 2008 Apr 11.

30.

Sorting through the heterogeneity of recurrent melanoma.

Jacobs LK, Lange JR, Balch CM.

Ann Surg Oncol. 2008 May;15(5):1280-1. doi: 10.1245/s10434-008-9823-3. Epub 2008 Mar 5. No abstract available.

31.

Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.

Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM.

J Clin Oncol. 2007 Apr 10;25(11):1363-8.

PMID:
17416855
32.

Melanoma.

Houghton AN, Coit DG, Daud A, Dilawari RA, Dimaio D, Gollob JA, Haas NB, Halpern A, Johnson TM, Kashani-Sabet M, Kraybill WG, Lange JR, Martini M, Ross MI, Samlowski WE, Sener SF, Tanabe KK, Thompson JA, Trisal V, Urist MM, Walker MJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Aug;4(7):666-84. No abstract available.

PMID:
16884669
33.

Sentinel lymph node biopsy.

Lange JR.

Clin Adv Hematol Oncol. 2003 Sep;1(9):529-31. No abstract available.

PMID:
16258444
34.

Screening for cutaneous melanoma.

Lange JR, Balch CM.

Surg Oncol Clin N Am. 2005 Oct;14(4):799-811. Review.

PMID:
16226692
35.

Melanoma in children: heightened awareness of an uncommon but often curable malignancy.

Lange JR, Balch CM.

Pediatrics. 2005 Mar;115(3):802-3. No abstract available.

PMID:
15741391
36.

Lymphatic mapping and sentinel node lymphadenectomy for cancer: an overview.

Balch CM, Lange JR.

Ann Surg Oncol. 2001 Oct;8(9 Suppl):1S-4S. Review. No abstract available.

PMID:
11599891
37.

The current status of sentinel node biopsy in the management of melanoma.

Lange JR.

Dermatol Surg. 2000 Aug;26(8):809-10. Review. No abstract available.

PMID:
10940072
38.
39.

Amelanotic melanoma: the great masquerader.

Koch SE, Lange JR.

J Am Acad Dermatol. 2000 May;42(5 Pt 1):731-4.

PMID:
10775846
40.

Is physician detection associated with thinner melanomas?

Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE.

JAMA. 1999 Feb 17;281(7):640-3.

PMID:
10029126
41.

Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.

Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA.

Ann Surg Oncol. 1998 Mar;5(2):140-9.

PMID:
9527267
42.

The surgical management of invasive primary melanoma: an update.

Lange JR.

Md Med J. 1997 May-Jun;46(5):251-4. Review. No abstract available.

PMID:
9159056
43.

A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy.

Pockaj BA, Yang JC, Lotze MT, Lange JR, Spencer WF, Steinberg SM, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA.

J Immunother Emphasis Tumor Immunol. 1994 Jan;15(1):22-8.

PMID:
8110727
44.

A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.

Lange JR, Steinberg SM, Doherty GM, Langstein HN, White DE, Shawker TH, Eastman RC, Jensen RT, Norton JA.

Surgery. 1992 Dec;112(6):1033-7; discussion 1037-8.

PMID:
1455306
45.

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA.

J Immunother (1991). 1992 Nov;12(4):265-71.

PMID:
1477077
46.

Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.

Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA.

J Immunol. 1992 Sep 1;149(5):1666-70.

PMID:
1506688
47.

Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis.

Lange JR, Alexander HR, Merino MJ, Doherty GM, Norton JA.

J Surg Res. 1992 Jun;52(6):555-9.

PMID:
1528030
48.

Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study.

Spencer WF, Linehan WM, Walther MM, Haas GP, Lotze MT, Topalian SL, Yang JC, Merino MJ, Lange JR, Pockaj BA, et al.

J Urol. 1992 Jan;147(1):24-30.

PMID:
1729540
49.

Effects of phenyl-2-aminoethyl sulfide, a novel dopamine-beta-hydroxylase substrate, on the cardiovascular system of the anesthetized dog.

Herman HH, Pollock SH, Padgette SR, Lange JR, Han JH, May SW.

J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):725-30.

PMID:
6195457

Supplemental Content

Loading ...
Support Center